Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

These small direct-point application pens are great. Keep one in the glove box, my kitchen 'junk' drawer, and the house ...

The company's nasal spray is a popular one for those who need a little extra help when it comes to their sinuses, and the over the counter medication is pretty easy to use, making it a first choice ...

awarding the company more money to upgrade and overhaul the service’s Mk 45 naval gun systems in an effort to improve their long-range strike and air defense capabilities, the company announced ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine ... “Some people have also wondered whether or not long-term use may predispose gateway activity; in other words, will ...

In the study, scientists used a spray. Nasal vestibulitis is not usually an emergency. However, if a person with a weakened immune system develops a fever, they should go to the emergency room ...

People were getting hit over the head with bottles and police had to resort to using pepper spray guns inside the strip club. The strip club was advised to shut down for the night. According to the ...

While promising, the nasal spray remains in early research stages. Critical considerations include long-term safety assessment, human clinical trial requirements, and comprehensive efficacy ...

A nasal spray of oxytocin significantly reduced acute ... While the hormone didn’t drastically impact long-term measures like generally perceived loneliness, quality of life or stress ...

The US Food and Drug Administration (FDA) has approved a supplemental new drug application allowing esketamine nasal spray (Spravato; Johnson & Johnson) to be used as a standalone treatment in ...

A ketamine-based nasal spray is officially the first and only standalone therapy ... cannot tolerate them," says Johnson & Johnson neuroscientist Bill Martin. "For too long, healthcare providers have ...